MR Tractography Using PGSE-OGSE ADC Maps for Tumor-Edema Distinction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Standard diffusion MR tractography methods fail to accurately distinguish between tumors and vasogenic edema in the brain, leading to inaccurate nerve fiber mapping and potential damage during surgical procedures.

Innovation Solution

An MR imaging system and method that employs PGSE and OGSE acquisitions to generate ADC maps, followed by an ADC ratio map, which visually distinguishes tumors and vasogenic edema, enabling precise nerve fiber tracking.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If standard diffusion MR tractography is used, then nerve fiber visualization is provided, but accurate distinction between tumor and vasogenic edema cannot be achieved

Engineering Contradiction:
Improvedistinction accuracy between tumor and edemaVSAvoidaccuracy of nerve fiber mapping
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent segments the diffusion imaging process into two distinct components: PGSE acquisition for structural tractography and OGSE acquisition for tumor/edema differentiation. By separating these functions into independent acquisition sequences and processing pathways, the system achieves both accurate nerve fiber mapping and reliable tumor/edema distinction without the conflicts present in standard unified approaches

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces ADC ratio maps as an intermediary processing step that mediates between the PGSE and OGSE acquisitions. This intermediary product combines information from both acquisition types to provide enhanced contrast between tumor and vasogenic edema, enabling accurate distinction while maintaining nerve fiber visualization capability

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If FA values are used to identify nerve fibers, then tractography can be generated, but FA values cannot distinguish tumor from vasogenic edema

Engineering Contradiction:
Improvetractography generationVSAvoidtumor vs edema differentiation information
Core Design Contradiction:
Ease of operationVSLoss of information

Solution Approach 1:

The patent adds a new dimensional parameter to the analysis by computing the ratio of ADC values from PGSE and OGSE acquisitions. This ratio creates an additional differentiation dimension that separates tumor from vasogenic edema, while the traditional FA values continue to provide nerve fiber tractography information without interference

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Measurement precision

If single acquisition sequence is used, then imaging time is reduced, but accurate distinction between tumor and edema cannot be achieved

Engineering Contradiction:
Improvetumor and edema differentiationVSAvoidimaging acquisition time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent performs preliminary actions by acquiring OGSE data specifically for tumor/edema differentiation before the main PGSE tractography acquisition. This preliminary OGSE acquisition enables subsequent ratio map computation that provides tumor/edema distinction, allowing the system to achieve accurate differentiation without requiring additional time-consuming post-processing

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables accurate visualization of nerve fibers extending through vasogenic edema, improving surgical planning by distinguishing between tumors and edema, thereby reducing the risk of damaging healthy nerve fibers.

Implementation Method 1

the subject or object is positioned in an examination region within a magnetic field BO that is generated by a main magnet and that extends in a longitudinal or z-direction, where magnetic moments of nuclei, such as protons, align with the magnetic field and precess about the magnetic field in a random order at the nuclei's Larmor frequency

Methodology Applied
Scientific EffectMagnetic field: Magnetic Field

Implementation Method 2

An excitation radiofrequency (RF) field B1, which is in a transverse or x-y plane and near the Larmor frequency, is generated by a coil and 'flips' the net magnetic moment of the nuclei from the z-direction to the x-y plane

Methodology Applied
Scientific EffectElectromagnetic induction: Electromagnetic Induction

Implementation Method 3

Magnetic field gradients (Gx, Gy, and Gz) are employed to encode the MR signals and scan through a k-space

Methodology Applied
Scientific EffectMagnetic field gradient: Magnetic Field

Implementation Method 4

An MR signal is emitted by the nuclei as the magnetic moment returns to the z-direction

Methodology Applied
Scientific EffectMagnetic resonance: Electromagnetic Induction

Data Source

PatentUS20260050054A1Method, system and/or computer readable medium for improved magnetic resonance (MR) imaging-based tractography
Publication Date: 2026.02.19 GE PRECISION HEALTHCARE LLC
  • US20260050054A1 patent drawing
  • US20260050054A1 patent drawing
  • US20260050054A1 patent drawing

AI summary

A magnetic resonance (MR) imaging system includes a main magnet configured to generate a magnetic field, gradients coils configured to generate time varying gradient magnetic fields, a radiofrequency (RF) transmit coil configured to generate RF signals, a controller configured to control the gradient and RF transmit coil based on a first sequence that includes a pulse gradient spin echo (PGSE) acquisition and an oscillating gradient spin echo (OGSE) acquisition, an RF receive coil configured to receive first MR signals generated in response to the PGSE and OGSE acquisitions, an image reconstructor configured to process the first MR signals and generate a first apparent diffusion coefficient (ADC) map for the PGSE acquisition and a second ADC map for the OGSE acquisition, and a processor configured to generate a seed point map based on the first and second ADC maps, wherein the seed point map visually distinguishes tumor and vasogenic edema.